|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.300 EUR | +1.22% |
|
+9.79% | +32.80% |
| Market Cap | 4.68Cr 5.32Cr 4.35Cr 3.99Cr 7.5Cr 512.59Cr 7.61Cr 52Cr 20Cr 252.01Cr 20Cr 20Cr 871.32Cr | P/E 2026 * |
-21.3x | P/E 2027 * | 208x |
|---|---|---|---|---|---|
| Enterprise Value | 4.53Cr 5.15Cr 4.21Cr 3.86Cr 7.26Cr 496.14Cr 7.37Cr 50Cr 20Cr 243.92Cr 19Cr 19Cr 843.36Cr | EV / Sales 2026 * |
4.11x | EV / Sales 2027 * | 2.87x |
| Free-Float |
29.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.22% | ||
| 1 week | +9.79% | ||
| Current month | +6.96% | ||
| 1 month | +10.96% | ||
| 3 months | +10.37% | ||
| 6 months | +18.57% | ||
| Current year | +32.80% |
| 1 week | 7.66 | 8.44 | |
| 1 month | 7.46 | 8.94 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.5 | 9.1 | |
| 3 years | 2.14 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | +9.79% | -1.19% | +234.68% | 5.32Cr | ||
| +0.86% | +1.43% | +48.50% | +160.39% | 1,06700Cr | ||
| +1.59% | +4.09% | +55.34% | +53.96% | 63TCr | ||
| +0.95% | +1.91% | +35.91% | +81.14% | 46TCr | ||
| +1.60% | +6.25% | +33.95% | +29.84% | 35TCr | ||
| -0.60% | +1.52% | +35.68% | +39.76% | 30TCr | ||
| -0.14% | +0.60% | +16.17% | +17.53% | 26TCr | ||
| +0.09% | -2.82% | -28.29% | -41.71% | 22TCr | ||
| +1.22% | +2.66% | +21.87% | +59.73% | 20TCr | ||
| -1.18% | -3.70% | +14.23% | +66.51% | 16TCr | ||
| Average | +0.46% | +2.17% | +23.22% | +70.18% | 36.43TCr | |
| Weighted average by Cap. | +0.55% | +1.95% | +35.81% | +77.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1Cr 1.25Cr 1.02Cr 93.87L 1.76Cr 120.61Cr 1.79Cr 12Cr 4.75Cr 59Cr 4.7Cr 4.6Cr 205.02Cr | 1.6Cr 1.82Cr 1.49Cr 1.37Cr 2.57Cr 175.43Cr 2.61Cr 18Cr 6.9Cr 86Cr 6.84Cr 6.69Cr 298.21Cr |
| Net income | -22.5L -25.62L -20.92L -19.2L -36.08L -25Cr -36.63L -2.48Cr -97.08L -12Cr -96.17L -94.1L -42Cr | 2L 3L 2L 2L 4L 2.74Cr 4L 27.61L 10.79L 1.35Cr 10.69L 10.46L 4.66Cr |
| Net Debt | -15L -17.08L -13.95L -12.8L -24.05L -16Cr -24.42L -1.66Cr -64.72L -8.09Cr -64.11L -62.73L -28Cr | -9L -10.25L -8L -8L -14.43L -9.87Cr -14.65L -99.39L -38.83L -4.85Cr -38.47L -37.64L -17Cr |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | €8.300 | +1.22% | 312 |
| 23/26/23 | €8.200 | +5.13% | 396 |
| 22/26/22 | €7.800 | -7.14% | 404 |
| 21/26/21 | €8.400 | +0.72% | 169 |
| 20/26/20 | €8.340 | +10.32% | 3,069 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.300EUR
Average target price
8.200EUR
Spread / Average Target
-1.20%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















